MACURE PHARMA ApS: Financial statements 2024
CVR: 35234748
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 39,051,226 and a net result of DKK 8,495,013 compared with DKK 8,790,375 the year before. That is an increase of 61.6% compared with the year before. Equity in the 2024 report amounted to DKK 14,979,645. The solvency ratio was 7.4%. The company had 13 employees in the financial year.
- Gross Profit
- DKK 39,051,226
- Profit/Loss
- DKK 8,495,013
- Equity
- DKK 14,979,645
- Total Assets
- DKK 202,510,136
- Employees
- 13
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 39.1 mio. | 8.5 mio. | 15 mio. | 13 |
| 2023 | - | 24.2 mio. | 8.8 mio. | 14.2 mio. | 13 |
| 2022 | - | 37.5 mio. | 17.9 mio. | 23.4 mio. | 10 |
| 2021 | - | 25 mio. | 5 mio. | 10.5 mio. | 6 |
| 2020 | - | 15.1 mio. | 5.3 mio. | 10.5 mio. | 10 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MACURE PHARMA ApS has won the tender "Amgros 2025 1.709.a" issued by Amgros I/S worth 145,756,745 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.710.a" issued by Amgros I/S worth 333,000,000 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 2.210.a" issued by Amgros I/S worth 36,886,685 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 2.1310.b" issued by Amgros I/S worth 129,999,998 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1390.b" issued by Amgros I/S worth 27,640,446 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1200.a" issued by Amgros I/S worth 101,036,383 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1205.a" issued by Amgros I/S worth 73,155,425 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1204.b" issued by Amgros I/S worth 9,670,700 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1202.a" issued by Amgros I/S worth 90,124,932 DKK.
About MACURE PHARMA ApS
MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity in the 2025 report amounted to DKK 18,033,649.